Oriola Oyj
OMXH:OKDBV
Relative Value
The Relative Value of one OKDBV stock under the Base Case scenario is 5.943 EUR. Compared to the current market price of 0.932 EUR, Oriola Oyj is Undervalued by 84%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
OKDBV Competitors Multiples
Oriola Oyj Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
FI |
O
|
Oriola Oyj
OMXH:OKDBV
|
169.1m EUR | 0.1 | -7 | 10.9 | -17.9 | |
US |
Mckesson Corp
NYSE:MCK
|
73.3B USD | 0.2 | 24.3 | 16.3 | 18.9 | ||
US |
Cencora Inc
NYSE:COR
|
44.1B USD | 0.2 | 23.8 | 11.7 | 16.4 | ||
US |
Amerisourcebergen Corp
NYSE:ABC
|
35.4B USD | 0.1 | 20.9 | 11.3 | 15.2 | ||
US |
Cardinal Health Inc
NYSE:CAH
|
24B USD | 0.1 | 43.1 | 8.9 | 11.9 | ||
US |
Henry Schein Inc
NASDAQ:HSIC
|
9.4B USD | 0.8 | 24.3 | 12.4 | 17.5 | ||
KR |
C
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 | |
CN |
Sinopharm Group Co Ltd
HKEX:1099
|
66.9B HKD | 0.1 | 6.9 | 1.7 | 2.1 | ||
IT |
Amplifon SpA
MIL:AMP
|
7.6B EUR | 3.3 | 46.9 | 15.2 | 30.3 | ||
CN |
Huadong Medicine Co Ltd
SZSE:000963
|
57.5B CNY | 1.4 | 19.5 | 14.9 | 14.9 | ||
CN |
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
52B CNY | 0.2 | 13.7 | 8.5 | 8.5 |